Efficacy and safety of donafenib as adjuvant therapy for patients with hepatocellular carcinoma undergoing curative resection: A retrospective, multicenter cohort study. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results